Retina Unplugged Transistor (https://transistor.fm) https://feeds.transistor.fm/retina-unplugged Paradigm’s Retina Unplugged Podcast is a platform that brings retina experts together for engaging discussions on timely topics that are relevant to clinical practice. Retina care continues to advance rapidly. This podcast provides a highly flexible, accessible, and engaging way to stay up to date on the latest clinical developments in the field and further your education by hearing from those who are at the forefront of innovation. © 2025 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC. b4174bd1-e6da-5964-8f59-44affd6dcf75 no en Mon, 29 Sep 2025 09:40:21 -0700 Tue, 02 Dec 2025 23:47:06 -0800 http://www.paradigmmc.com https://img.transistor.fm/pPQzff2ix6WAciJHNFetgYXcXh2vJLNS4nu3Q-zUmIs/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iNWQy/OTZiNTZhODFjMmZi/ZjJhMWVhNzVjNWJk/NDY3OS5qcGc.jpg Retina Unplugged http://www.paradigmmc.com episodic Paradigm Medical Communications, LLC Paradigm’s Retina Unplugged Podcast is a platform that brings retina experts together for engaging discussions on timely topics that are relevant to clinical practice. Retina care continues to advance rapidly. This podcast provides a highly flexible, accessible, and engaging way to stay up to date on the latest clinical developments in the field and further your education by hearing from those who are at the forefront of innovation. Paradigm’s Retina Unplugged Podcast is a platform that brings retina experts together for engaging discussions on timely topics that are relevant to clinical practice. CME, Retina, Medical, Education, Ophthalmology Paradigm Medical Communications, LLC No No Common Practice Dilemmas in the Age of Second-Generation Therapy 1 1 Common Practice Dilemmas in the Age of Second-Generation Therapy full 7893b37a-8cbc-4d53-aed8-c19f3118bbd6 https://share.transistor.fm/s/93823b10 Please CLICK HERE (www.paradigmmc.com/1401) to review the CME information and complete the pretest for this activity.


  • (00:00) - Intro
  • (00:46) - The Current Clinic Capacity Crisis
  • (07:24) - The Impact of Second Generation Treatments on Patients, Caregivers, and Retina Practices
  • (15:41) - What Are We Seeing in Clinical Practice
  • (25:01) - Home OCT and Future Treatment Protocols


Treatment paradigms are shifting with the advent of second-generation therapies (eg, faricimab and aflibercept 8 mg) for retinal vascular disease. How will this affect your practice? Listen to renowned experts as they share their own experiences with second-generation therapies and discuss related innovations, clinical challenges, and practical solutions (eg, optical coherence tomography monitoring, the role of biomarkers, and patient engagement) in this lively podcast activity.


When you are finished, please CLICK HERE (www.paradigmmc.com/1401) to complete the posttest and evaluation.

TRANSCRIPT

REFERENCES


]]> Please CLICK HERE (www.paradigmmc.com/1401) to review the CME information and complete the pretest for this activity.


  • (00:00) - Intro
  • (00:46) - The Current Clinic Capacity Crisis
  • (07:24) - The Impact of Second Generation Treatments on Patients, Caregivers, and Retina Practices
  • (15:41) - What Are We Seeing in Clinical Practice
  • (25:01) - Home OCT and Future Treatment Protocols


Treatment paradigms are shifting with the advent of second-generation therapies (eg, faricimab and aflibercept 8 mg) for retinal vascular disease. How will this affect your practice? Listen to renowned experts as they share their own experiences with second-generation therapies and discuss related innovations, clinical challenges, and practical solutions (eg, optical coherence tomography monitoring, the role of biomarkers, and patient engagement) in this lively podcast activity.


When you are finished, please CLICK HERE (www.paradigmmc.com/1401) to complete the posttest and evaluation.

TRANSCRIPT

REFERENCES


]]> Mon, 29 Sep 2025 09:10:57 -0700 Paradigm Medical Communications, LLC Paradigm Medical Communications, LLC 1826 Please CLICK HERE (www.paradigmmc.com/1401) to review the CME information and complete the pretest for this activity.


  • (00:00) - Intro
  • (00:46) - The Current Clinic Capacity Crisis
  • (07:24) - The Impact of Second Generation Treatments on Patients, Caregivers, and Retina Practices
  • (15:41) - What Are We Seeing in Clinical Practice
  • (25:01) - Home OCT and Future Treatment Protocols


Treatment paradigms are shifting with the advent of second-generation therapies (eg, faricimab and aflibercept 8 mg) for retinal vascular disease. How will this affect your practice? Listen to renowned experts as they share their own experiences with second-generation therapies and discuss related innovations, clinical challenges, and practical solutions (eg, optical coherence tomography monitoring, the role of biomarkers, and patient engagement) in this lively podcast activity.


When you are finished, please CLICK HERE (www.paradigmmc.com/1401) to complete the posttest and evaluation.

TRANSCRIPT

REFERENCES


]]> CME, Retina, Medical, Education, Ophthalmology No